Loading...

Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review

Immune checkpoint inhibitors (ICIs) belong to a new group of anticancer drugs targeting T-cell proteins involved in the activation of immune response toward malignancies. Their introduction into clinical practice was a milestone in modern cancer treatment. However, the significant advantage of ICIs...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Maria Stelmachowska-Banaś, Izabella Czajka-Oraniec
Format: Artigo
Sprog:Inglês
Udgivet: Bioscientifica 2020-10-01
Serier:Endocrine Connections
Fag:
Online adgang:https://ec.bioscientifica.com/view/journals/ec/9/10/EC-20-0342.xml
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!